Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2014 (2014), Article ID 580569, 4 pages
http://dx.doi.org/10.1155/2014/580569
Research Article

Urinary Iodine Clearance following Iodinated Contrast Administration: A Comparison of Euthyroid and Postthyroidectomy Subjects

1University of Manitoba, Winnipeg, MB, Canada R3T 2N2
2Department of Radiology, University of Manitoba, Winnipeg, MB, Canada R3T 2N2
3Sector Strategies Division, Risk Management Bureau, Safe Environments Directorate, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada K1A 0K9
4Department of Medicine (C5121), 409 Tache Avenue, Winnipeg, MB, Canada R2H 2A6

Received 22 August 2014; Revised 15 October 2014; Accepted 20 October 2014; Published 12 November 2014

Academic Editor: Julie A. Sosa

Copyright © 2014 Janice D. Ho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. van der Molen, H. S. Thomsen, S. K. Morcos et al., “Effect of iodinated contrast media on thyroid function in adults,” European Radiology, vol. 14, no. 5, pp. 902–907, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. H. M. Pluijmen, C. Eustatia-Rutten, B. M. Goslings et al., “Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma,” Clinical Endocrinology, vol. 58, no. 4, pp. 428–435, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. Cupp and S. Newman, “Influence of iodalphionic acid priodax with and without thyrotropin , on thyroidal I 131 uptake in euthyroid patients,” The Journal of Clinical Endocrinology and Metabolism, vol. 17, no. 1, pp. 94–98, 1957. View at Publisher · View at Google Scholar
  5. W. R. Rogers and L. R. Robbins, “Idiopathic (cholografin) administration; its effect on the thyroid uptake of I131 and the serum precipitable iodine in euthyroid persons,” The New England Journal of Medicine, vol. 253, no. 10, pp. 424–425, 1955. View at Publisher · View at Google Scholar
  6. R. J. Amdur and E. L. Mazzaferri, “Intravenous iodinated contrast effects iodine uptake for months,” in Essentials of Thyroid Cancer Management, pp. 211–213, Springer, New York, NY, USA, 1st edition, 2005. View at Publisher · View at Google Scholar
  7. F. Pancin, M. Schlumberger, H. Dralle et al., “European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium,” European Journal of Endocrinology, vol. 154, pp. 787–803, 2006. View at Publisher · View at Google Scholar
  8. S. J. Schwab, R. L. Christensen, K. Dougherty, and S. Klahr, “Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples,” Archives of Internal Medicine, vol. 147, no. 5, pp. 943–944, 1987. View at Publisher · View at Google Scholar · View at Scopus
  9. V. C. Chitalia, J. Kothari, E. J. Wells et al., “Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio,” Clinical Nephrology, vol. 55, no. 6, pp. 436–447, 2001. View at Google Scholar · View at Scopus
  10. WHO, UNICEF, and ICCIDD, Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination. A Guide for Programme Managers, WHO Publications, Geneva, Switzerland, 3rd edition, 2007.
  11. T. Ohashi, M. Yamaki, C. S. Pandav, M. G. Karmarkar, and M. Irie, “Simple microplate method for determination of urinary iodine,” Clinical Chemistry, vol. 46, no. 4, pp. 529–536, 2000. View at Google Scholar · View at Scopus
  12. O. P. Soldin, S. J. Soldin, and J. C. Pezzullo, “Urinary iodine percentile ranges in the United States,” Clinica Chimica Acta, vol. 328, no. 1-2, pp. 185–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Padovani, T. Kasamatsu, C. Nakabashi et al., “One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy,” Thyroid, vol. 22, no. 9, pp. 926–930, 2012. View at Publisher · View at Google Scholar
  14. G. L. Nimmons, G. F. Funk, M. M. Graham, and N. A. Pagedar, “Urinary iodine excretion after contrast computed tomography scan: Implications for radioactive iodine use,” JAMA Otolaryngology—Head and Neck Surgery, vol. 139, no. 5, pp. 479–482, 2013. View at Publisher · View at Google Scholar · View at Scopus